Sterling Capital Management »

Acumen Pharmaceuticals shares owned by Sterling Capital Management

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by Sterling Capital Management from 13F filings

Historical chart of Sterling Capital Management investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by Sterling Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by Sterling Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.5k 1.4k 1.72
2024-09-30 $329 133 2.48

More positions owned by Sterling Capital Management

Microsoft Corporation (MSFT)
Vanguard S&p 500 Etf Etf (VOO)
NVIDIA Corporation (NVDA)
Charles Schwab Corporation (SCHW)
Apple (AAPL)
UnitedHealth (UNH)
Raymond James Financial (RJF)
Amazon (AMZN)
Ameriprise Financial (AMP)
Automatic Data Processing (ADP)
Analog Devices (ADI)
Anthem (ELV)
Home Depot (HD)
Pepsi (PEP)
Everest Re Group (EG)

View all positions for Sterling Capital Management

Top funds holding Acumen Pharmaceuticals

RA Capital Management
Sands Capital Ventures
Franklin Resources
BlackRock
FMR
Vanguard Group
Rock Springs Capital Management
Knollwood Investment Advisory
Millennium Management
Alyeska Investment Group
Jpmorgan Chase & Co
Geode Capital Management
Laurion Capital Management
Hudson Bay Capital Management
Pathstone Holdings

View all funds holding Acumen Pharmaceuticals